AI-Enabled mRNA & Nucleic Acid Sequence Design Software Market
完整報告名稱與涵蓋範圍
AI-Enabled mRNA & Nucleic Acid Sequence Design Software Market Size, Share & Trends Analysis Report, By Software Function (Codon and UTR Optimization, RNA Structure and Stability Prediction, Immunogenicity and Expression Modelling, Manufacturability and Sequence Feasibility Screening), By Deployment (Cloud and SaaS Platforms, On-Premise and Enterprise Licences, Design-as-a-Service and Partnered Programs), By Application (mRNA Vaccines and Therapeutics, Gene Editing and Cell Engineering Payloads, Oligonucleotide and Aptamer Design, Synthetic Biology and Research), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The AI-enabled mRNA and nucleic acid sequence design software market covers computational platforms, models and design services that optimise codon usage, untranslated regions, secondary structure, stability, immunogenicity and manufacturability of messenger RNA, gene-editing payloads and other nucleic acid sequences. Wet-lab synthesis, general bioinformatics suites without design capability and small-molecule discovery software are excluded.
Sequence design has moved from rule-based codon tables to machine-learning models trained on expression, degradation and immunogenicity data, and to language models that treat RNA as a sequence to be generated and scored. Improvements in half-life and expression achieved through structure-aware design translate directly into lower doses and cheaper manufacturing, which is why RNA developers, reagent suppliers and technology companies have invested in proprietary and licensable tools. Platforms increasingly integrate with high-throughput synthesis and screening to create closed learning loops, offer manufacturability checks for long or repetitive sequences and extend to oligonucleotide, aptamer and synthetic biology design. Data access, model validation and intellectual property over designed sequences shape competition.
North America leads platform development, with China and Europe hosting notable innovators and Japanese and Korean RNA companies adopting design tools. Competition involves nucleic acid manufacturers offering design services, AI-native design start-ups, technology groups releasing biological foundation models and laboratory informatics vendors.
The InsightAce study supplies US$ forecasts for all software function, deployment, application and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-Enabled mRNA & Nucleic Acid Sequence Design Software Market Snapshot
Chapter 4. Global AI-Enabled mRNA & Nucleic Acid Sequence Design Software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Software Function Estimates & Trend Analysis
5.1. Software Function & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Software Function:
5.2.1. Codon and UTR Optimization
5.2.2. RNA Structure and Stability Prediction
5.2.3. Immunogenicity and Expression Modelling
5.2.4. Manufacturability and Sequence Feasibility Screening
Chapter 6. Market Segmentation 2: By Deployment Estimates & Trend Analysis
6.1. Deployment & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Deployment:
6.2.1. Cloud and SaaS Platforms
6.2.2. On-Premise and Enterprise Licences
6.2.3. Design-as-a-Service and Partnered Programs
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. mRNA Vaccines and Therapeutics
7.2.2. Gene Editing and Cell Engineering Payloads
7.2.3. Oligonucleotide and Aptamer Design
7.2.4. Synthetic Biology and Research
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. CDMOs and Reagent Suppliers
8.2.3. Academic and Research Institutes
Chapter 9. AI-Enabled mRNA & Nucleic Acid Sequence Design Software Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. TriLink BioTechnologies (Officinae Bio)
11.2. Inceptive, Inc.
11.3. Baidu Research (LinearDesign)
11.4. GenScript Biotech Corporation
11.5. Integrated DNA Technologies, Inc. (Danaher)
11.6. Atlas Bio
11.7. Benchling, Inc.
11.8. Moderna, Inc. (Internal Platforms)
11.9. NVIDIA Corporation (BioNeMo)
11.10. Ginkgo Bioworks Holdings, Inc.
11.11. Twist Bioscience Corporation
11.12. Eterna Therapeutics (Legacy)
11.13. Nucleic Acid Design Vendors (Codon Optimization Tools)
11.14. Insilico Medicine
11.15. EvolutionaryScale, PBC
圖表清單 List of Tables & Figures
Table 1. Global AI-Enabled mRNA & Nucleic Acid Sequence Design Software Revenue Forecast by Software Function, 2026-2035 (US$ Mn)
Figure 1. Global AI-Enabled mRNA & Nucleic Acid Sequence Design Software Market Snapshot, 2026 & 2035
Table 2. Global AI-Enabled mRNA & Nucleic Acid Sequence Design Software Revenue Forecast by Deployment, 2026-2035 (US$ Mn)
Figure 2. Global AI-Enabled mRNA & Nucleic Acid Sequence Design Software Market Share by Deployment, 2026 & 2035
Table 3. Global AI-Enabled mRNA & Nucleic Acid Sequence Design Software Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. AI Sequence Design Workflow from Objective Definition to Synthesized Construct
Table 4. Global AI-Enabled mRNA & Nucleic Acid Sequence Design Software Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Expression and Stability Gains Reported from Structure-Aware mRNA Design
Table 5. North America AI-Enabled mRNA & Nucleic Acid Sequence Design Software Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific AI-Enabled mRNA & Nucleic Acid Sequence Design Software Growth Opportunity Analysis
Table 6. Europe AI-Enabled mRNA & Nucleic Acid Sequence Design Software Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Business Models: SaaS, Enterprise Licensing and Design-as-a-Service
Table 7. Asia Pacific AI-Enabled mRNA & Nucleic Acid Sequence Design Software Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key AI-Enabled mRNA & Nucleic Acid Sequence Design Software Market Participants
Table 8. Latin America and Middle East & Africa AI-Enabled mRNA & Nucleic Acid Sequence Design Software Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們